Trinity Biotech (TRIB) Other Accumulated Expenses (2016 - 2024)
Trinity Biotech's Other Accumulated Expenses history spans 16 years, with the latest figure at $3.0 million for Q4 2024.
- On a quarterly basis, Other Accumulated Expenses rose 4.15% to $3.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.0 million, a 4.15% increase, with the full-year FY2024 number at $3.0 million, up 4.15% from a year prior.
- Other Accumulated Expenses hit $3.0 million in Q4 2024 for Trinity Biotech, up from $1.8 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for TRIB hit a ceiling of $69.3 million in Q4 2020 and a floor of $1.8 million in Q1 2024.
- Historically, Other Accumulated Expenses has averaged $17.0 million across 5 years, with a median of $13.0 million in 2022.
- Biggest five-year swings in Other Accumulated Expenses: grew 7.87% in 2020 and later crashed 83.54% in 2024.
- Tracing TRIB's Other Accumulated Expenses over 5 years: stood at $69.3 million in 2020, then decreased by 0.79% to $68.8 million in 2021, then tumbled by 82.16% to $12.3 million in 2022, then crashed by 76.61% to $2.9 million in 2023, then increased by 4.15% to $3.0 million in 2024.
- Business Quant data shows Other Accumulated Expenses for TRIB at $3.0 million in Q4 2024, $1.8 million in Q3 2024, and $1.8 million in Q2 2024.